Andere talen ProPhase Labs, Inc.

Aandelen

PRPH

US74345W1080

Geschatte realtime Cboe BZX Andere beurzen 20:29:36 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,27 ^USD	+1,54%		+6,06%	+16,15%

16/04	ProPhase Labs, Inc. Onthult Project ZenQ-AI	CI
15/03	Transcript : ProPhase Labs, Inc., 2023 Earnings Call, Mar 15, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9	14:01
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024	25/04
Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup	16/04
ProPhase Labs Unveils Project ZenQ-AI	16/04
ProPhase Labs, Inc. Unveils Project ZenQ-AI	16/04
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024	10/04
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	02/04
MENADNA and ProPhase Labs' (NASDAQ: PRPH) Wholly-Owned Subsidiary, Nebula Genomics, Announce Strategic Partnership to Enhance Genomic Testing in Jordan, Oman and Iraq	18/03
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives	15/03
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
North American Morning Briefing : Inflation -2-	15/03
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024	08/03
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART	20/02
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test	20/02
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir	14/02
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir	14/02
Sidus Space Appoints Bill White as Chief Financial Officer	09/02
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics	30/01
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts	23/01
ProPhase Labs Names Jed Latkin as Chief Operating Officer	04/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ProPhase Labs, Inc.

Aandelen

PRPH

US74345W1080

Andere talen

Filters